Lipum AB
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company develops SOL-116, a humanized antibody that is in late preclinical phase for the treatment of juvenile idiopathic arthritis and rheumatoid arthritis diseases. It has a collaboration with NorthXBiologies for production of SOL-116 setatt; and a… Read more
Lipum AB (LIPUM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 1.465x
Based on the latest financial reports, Lipum AB (LIPUM) has a cash flow conversion efficiency ratio of 1.465x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.95 Million) by net assets (Skr-4.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lipum AB - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Lipum AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lipum AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lipum AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nureca Limited
NSE:NURECA
|
0.022x |
|
Equites Property Fund Ltd
JSE:EQU
|
0.035x |
|
Profusa, Inc. Common Stock
NASDAQ:PFSA
|
0.313x |
|
PARKER-HANNIFIN CO. - Dusseldorf Stock Exchang
DU:PAR
|
0.058x |
|
PIONEER MEDIA HOLDINGS
F:6NU
|
N/A |
|
Noble Helium Ltd
AU:NHE
|
-0.026x |
|
Levinstein Eng
TA:LEVI
|
-0.015x |
|
Noble Finance Company
PINK:NBLWF
|
0.041x |
Annual Cash Flow Conversion Efficiency for Lipum AB (2018–2025)
The table below shows the annual cash flow conversion efficiency of Lipum AB from 2018 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr-4.74 Million | Skr-34.94 Million | 7.368x | +287.28% |
| 2024-12-31 | Skr22.00 Million | Skr-86.53 Million | -3.934x | +50.21% |
| 2023-12-31 | Skr4.57 Million | Skr-36.13 Million | -7.902x | -322.88% |
| 2022-12-31 | Skr28.05 Million | Skr-52.41 Million | -1.869x | -51.90% |
| 2021-12-31 | Skr27.88 Million | Skr-34.30 Million | -1.230x | +79.51% |
| 2020-12-31 | Skr3.23 Million | Skr-19.37 Million | -6.002x | -391.71% |
| 2019-12-31 | Skr15.87 Million | Skr-19.37 Million | -1.221x | +98.83% |
| 2018-12-31 | Skr185.26K | Skr-19.37 Million | -104.555x | -- |